← FDA DRUG APPROVALS

FDA ANDA · ANDA202246

LEVONORGESTREL

Sponsor: ALVOGEN

APPLICATION
ANDA202246
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-05
LATEST ACTION
2018-02-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LEVONORGESTRELDiscontinued
LEVONORGESTREL 1.5MG · TABLET · ORAL

Approval history

2018-02-20Labeling · Supplement 4 · standardAP
2016-07-06Labeling · Supplement 3 · standardAP
2016-07-06Labeling · Supplement 1 · standardAP
2015-06-05OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →